第一单位：
Department of Medical Oncology, Institut Curie, Paris, France.;Université Paris Cité, Paris, France.;Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.
作者：
Anne-Sophie,Hamy [1]
;
Agathe,Chabassier [2]
;
Clara,Sebbag [1]
;
Christine,Rousset-Jablonski [3]
;
Clémentine,Berkach [4]
;
Isabelle,Ray-Coquard [3]
;
Laura,Sablone [5]
;
Lauren,Darrigues [6]
;
Elise,Dumas [2]
;
Angélique,Bobrie [7]
;
William,Jacot [7]
;
Marc,Espié [8]
;
Sylvie,Giacchetti [8]
;
Floriane,Jochum [9]
;
Aullène,Toussaint [1]
;
Geneviève,Plu-Bureau [10]
;
Lorraine,Maitrot-Mantelet [10]
;
Anne,Gompel [10]
;
Paul,Gougis [11]
;
Raphaëlle,Bas [12]
;
Christine,Decanter [13]
;
Bernard,Asselain [14]
;
Charles,Coutant [15]
;
Lili,Sohn [5]
;
Guillemette,Jacob [5]
;
Claire,Saule [12]
;
Sophie,Frank [12]
;
Judith,Abécassis [16]
;
Florence,Coussy [1]
;
Fabien,Reyal [17]
;
Seintinelles Research Network
作者单位：
Department of Medical Oncology, Institut Curie, Paris, France.;Université Paris Cité, Paris, France.;Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.
[1]
Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.
[2]
Centre Léon Bérard, Lyon, France.;RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France.
[3]
Unité de Génétique Clinique, Hôpital Saint-Louis, APHP, France.
[4]
Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.
[5]
Department of Surgical Oncology, Institut Curie, Paris, France.;Université Paris Cité, Paris, France.
[6]
Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France.
[7]
Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.;Université Paris Cité, Paris, France.
[8]
Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.;Department of Gynecology, Strasbourg University Hospital, Strasbourg, France.
[9]
Department of Gynecology, Hôpital Cochin, Paris, France.;Université Paris Cité, Paris, France.
[10]
Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.;Sorbonne Université, INSERM, UNICO-GRECO Cardio-oncology Program, Department of Pharmacology, GRC27, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
[11]
Department of Medical Oncology, Institut Curie, Paris, France.;Université Paris Cité, Paris, France.
[12]
ART Department, Centre Hospitalier Régional Lille, Lille, France.
[13]
Department of Biostatistics, Unicancer, Paris, France.
[14]
Clinical Research Department, Centre Georges-François Leclerc (Unicancer), Dijon, France.
[15]
Project-team Soda, Inria Saclay, Palaiseau, France.;Institut Polytechnique de Paris, Palaiseau, France.
[16]
Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.;Department of Surgical Oncology, Institut Curie, Paris, France.;Université Paris Cité, Paris, France.
[17]
DOI
10.1016/j.eclinm.2025.103392
PMID
40777863
发布时间
2025-08-10
换一批
